Rosamund Vallings

Source:www.stuff.co.nz

Rosamund Vallings, MD, MNZM, MB, BS, is one of New Zealand’s leading authorities on Chronic Fatigue Syndrome. She served voluntarily for over 27 years as President of the Associated New Zealand ME Society (ANZMES) and later as Medical Adviser and Committee Member.

She is one of the authors of the 2011 case definition, International Consensus Criteria and the 2017 Pediatric Primer for Physicians.

Awards

• 2008, Member of the New Zealand Order of Merit in the New Year honours list (MNZM)
• 2011, Nelson Gantz Outstanding Clinician Award awarded to a physician who emulates Nelson Gantz's clinical acumen, his passion for medicine, and his empathy for persons with CFS/FM awarded by International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
• 2019, Finalist for the Metlifecare Senior New Zealander of the Year

Committees and boards

International Consensus Criteria

Dr. Vallings was one of the authors of the 2011 case definition, International Consensus Criteria.

IACFS/ME Primer (2014)

Dr Vallings was one of the authors of the 2014 IACFSME Primer for Clinical Practitioners.

Pediatric Primer (2017)

Dr. Vallings was one of the authors of the 2017 Pediatric Primer for Physicians published in Frontiers in Pediatrics.

• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer by Peter Rowe, Rosemary A. Underhill, Kenneth J. Friedman, Alan Gurwitt, Marvin S. Medow, Malcolm S. Schwartz, Nigel Speight, Julian M. Stewart, Rosamund Vallings and Katherine S. Rowe - (Full Text)

Advocacy

Open Letter to The Lancet

In response to The Lancet's publication of the controversial PACE trial in 2011, three open letters to the editor of The Lancet urged the editor, Richard Horton, to commission a fully independent review of the PACE trial. In 2016, Dr. Vallings, along with 41 colleagues in the ME/CFS field, signed the second letter. In 2018, Dr. Vallings, along with over 100 colleagues signed a third letter.

• February 10, 2016, An open letter to The Lancet, again - Virology blog
• July 9, 2018, Trial By Error: Yet Another Appeal to The Lancet, With More On Board

Articles

• 2004, AACFS 7th International Conference - Conference Reports
• 2004, Hypnosis in the Management of Chronic Fatigue Syndrome
• 2015 Invest in ME Conference Report, by Dr. Rosamund Vallings
• 2016, Invest in ME C11 2016 Conference Report, by Dr. Rosamund Vallings
• 2019, Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - (Full text)

Talks and interviews

• 2010, Dr Ros Vallings on ME/CFS and XMRV
• 2013, Presentation by Dr Ros Vallings at seminar held by Emerge Australia (formerly ME/CFS Australia (Victoria))
• 2013, Dr Ros Vallings talks about M.E. and feelings of isolation
• 2014, CFS/ME lecture | Dr Ros Vallings | Sep-2014

Books

• 2013, Chronic Fatigue Syndrome M.E.: Symptoms, Diagnosis, Management
• 2015, Managing ME/CFS: A guide for young people
• 2017, The Pocket Guide to Chronic Fatigue Syndrome/ME: Key Facts and Tips for Improved Health

Research studies

• 2019, Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome - (Full text)
• 2019, Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - (Full text)
• 2020, A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction - (Full text)

Learn more

• Nov 20, 2016, Doctor wins international award in Times Live New Zealand

See also

• Associated New Zealand ME Society
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer
• New Zealand
• Richie Barnett

Associated New Zealand ME Society (ANZMES) - A New Zealand group for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients and their caregivers.

See Associated New Zealand ME Society.

See chronic fatigue syndrome.

See myalgic encephalomyelitis.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

mitochondria Important parts of the biological cell, with each mitochondrion encased within a mitochondrial membrane. Mitochondria are best known for their role in energy production, earning them the nickname "the powerhouse of the cell". Mitochondria also participate in the detection of threats and the response to these threats. One of the responses to threats orchestrated by mitochondria is apoptosis, a cell suicide program used by cells when the threat can not be eliminated.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.